Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
acetylcholine
acromegaly
advances in neurology
adverse drug reaction
affective disorders
agitation
akathisia
algorithm
alpha methyldopa hydrazine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
amphetamines, dyskinesia associated with
amygdala
anesthesia, general
anticholinergic drugs
anticholinergic drugs, side effects of
antidepressant
antihistamines
anxiety
apomorphine
aprazolam
arrhythmia, cardiac
aspartate aminotransferase
asterixis
atypical
autonomic dysfunction
axillary nerve
ballismus, bilateral
behavioral disorder
benzodiazepine
bladder dysfunction
bradykinesia
bromocriptine
Brueghel's syndrome
burning paresthesia
buspirone
carbidopa
CAT scan, emission
catechol-o-methyltransferase inhibitor
chest pain
chorea
clonazepam
clozapine
complications
confusion
controversies in neurology
Coombs test, positive
cough
delirium
delusion
dementia
deprenyl
depression
desipramine
diabetes mellitus
diarrhea
dopamine
dopamine agonist
drug abuse
drug addiction
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dyspnea
dystonia
dystonia, treatment of
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, triphasic delta waves
encephalopathy
entacapone
enzyme inhibition
enzyme, serum
epidemiology of neurology
excitotoxin
genetic neurologic disorders
globus pallidus, stimulation
groaning
hallucination
hallucination, visual
haloperidol
hemiballismus
hemidystonia
hunger
hyperthermia
iatrogenic neurologic disorders
imipramine
infusion pump
intellectual deficit
isoniazid
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, plasma concentration
L-dopa, potentiators of
Lewy body
Lewy body disease, diffuse
livedo reticularis
liver function enzymes
locus ceruleus, lesion of
lorazepam
manic-depressive
melanoma, malignant
memory
memory, impairment of
mental status, abnormal
mitochondrial disease
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
myoclonic jerks
myoclonus
myoclonus, sleep
nausea and vomiting
neuroendocrinology
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic signs
neurologist
neuronal degeneration
neuropathology
nigrostriatal pathway
nortriptyline
olanzapine
ondansetron
oral contraceptives
oral contraceptives, choreiform movements with
orthostatic hypotension
pain
pallidotomy
panic attacks
papaverine
paranoia
paresthesias
Parkinson disease
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug holiday
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, postencephalitic
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism plus syndrome
Parkinsonism syndrome
parsidol
patient information and support
pergolide
phenothiazine
phenothiazine, dyskinesia associated with
phobias
pramipexole
procyclidine
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
pyridoxine
quetiapine
raphe nuclei
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
review article
rigidity
ritalin
ropinirole
selective serotonin reuptake inhibitors
serotonin antagonist
serum alanine aminotransferase
sinemet
single photon emission computed tomography
sleep pathology and physiology
start hesitation
stimulation, deep brain
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
tardive dyskinesia
tolcapone
tonic foot response
torticollis
trazodone
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tricyclic antidepressant
trigeminal neuralgia
vitamin, multiple
vocalizations
Showing articles 500 to 550 of 982 << Previous Next >>

Serial Electrocardiographic Assessments Significantly Improve Detection of Atrial Fibrillation 2.6-Fold in Patients With Acute Stroke
Stroke 39:480-482, Douen,A.G.,et al, 2008

Seizures on Hearing the Alarm Clock
Lancet 370:2172, Vollmar,C.,et al, 2007

When the Worst Headache Becomes the Worst Heartache!
Stroke 38:3292-3295, Hakeem,A.,et al, 2007

Warfarin Versus Aspirin for Stroke Prevention in an Elderly Community Population With Atrial Fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A Randomised Controlled Trial
Lancet 370:493-503,460, Mant,J.,et al, 2007

Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Stroke 38:2459-2463,2409, Baruch,L.,et al, 2007

Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke: A Systematic Review
Stroke 38:2935-2940, Liao,J.,et al, 2007

Direct Thrombin Inhibition and Stroke Prevention in Elderly Patients With Atrial Fibrillation: Experience From the SPORTIF III and V Trial
Stroke 38:2965-2971, Ford,G.A.,et al, 2007

Neurological,Cardiological,and Oculomotor Progression in 104 Patients with Freidreich Ataxia During Long-Term Follow-Up
Arch Neurol 64:558-564, Rabai,P.,et al, 2007

Antithrombotic and Interventional Treatment Options in Cardioembolic Transient Ischaemic Attack and Ischaemic Stroke
JNNP 78:14-24, McCabe,D.J.H. &Rakhit,R.D., 2007

Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke 38:874-880, Akins,P.T.,et al, 2007

Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007

Combining Aspirin With Oral Anticoagulant Therapy: Is This a Safe and Effective Practice in Patients With Atrial Fibrillation?
Stroke 38:1652-1654, Gorelick,P.B., 2007

Independent Predictors of Stroke in Patients with Atrial Fibrillation
Neurol 69:546-554, The Stroke Risk in Atrial Fibrillation Working Group, 2007

Video-Electrographic and Clinical Features in Patients with Ictal Asystole
Neurol 69:434-441,423, Schuele,S.U.,et al, 2007

Frequent Atrial Premature Beats Predict Paroxysmal Atrial Fibrillation in Stroke Patients
Stroke 38:2292-2294, Wallmann,D.,et al, 2007

Myocardial Injury and Long-Term Mortality Following Moderate to Severe Carbon Monoxide Poisoning
JAMA 295:398-402, Henry,C.R.,et al, 2006

Familial Dopa-Responsive Cervical Dystonia
Neurol 66:599-601, Schneider,S.A.,et al, 2006

Metabolic Disease and Stroke: MELAS
emedicine.com, Mandava,P.,et al, 2006

Insular Involvement in Brain Infarction Increases Risk for Cardiac Arrhythmia and Death
Ann Neurol 59:691-699, Abboud,H.,et al, 2006

Electrocardiogram in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients Without Any Clinical Evidence of Coronary Artery Disease
Stroke 37:1100-1102, Cumurciuc,R.,et al, 2006

Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006

Central Nervous System Injury Associated with Cardiac Surgery
Lancet 368:694-703, Newman,M.F.,et al, 2006

Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: Yes
Stroke 37:3052-3053,3056, Chamorro,., 2006

Immediate Angicoagulation for Acute Stroke in Atrial Fibrillation: No
Stroke 37:3054-3055,3056, Sandercock,P., 2006

Unrecognized Myocardial Infarction and the Risk of Stroke: The Rotterdam Study
Neurol 67:1635-1639, Ikram,M.A.,et al, 2006

Not All Patients With Atrial Fibrillation-Associated Ischemic Stroke Can Be Started on Anticoagulant Therapy
Stroke 37:1217-1220, Somerfield,J.,et al, 2006

The Insular Cortex and Cardiac Response to Stroke
Neurol 66:1296-1297, Cheshire,W.P. Jr., &Saper,C.B., 2006

Clopidogrel Plus Aspirin Versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): A Randomised Controlled Trial
Lancet 367:1903-1912,1877, The ACTIVE Writing Group on behalf of the ACTIVE Investigators, 2006

Dopa-responsive Dystonic Camptocormia
Neurol 66:1779, Van Gerpen,J.A., 2006

Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Circulation 114:759-765, Oral,H.,et al, 2006

Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No Previous History of Stroke or Transient Ischemic Attacks
Stroke 37:274-275, Aguilar,M.I. &Hart,R.G., 2006

Location and Outcome of Anticoagulant-Associated Intracerebral Hemorrhage
Neurocrit Care 05:197-201, Flaherty, M.L.,et al, 2006

Progressive Myoclonic Epilepsies: A Review of Genetic and Therapeutic Aspects
Lancet Neurol 4:239-248, Shahwan, A., et al, 2005

Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
Stroke 36:1115-1119, Marini,C.,et al, 2005

Should a Patient With Primary Intracerebral Haemorrhage Receive Antiplatelet or Anticoagulant Therapy?
BMJ 331:439-442, Wani,M.,et al, 2005

Postictal Neurogenic Stunned Myocardium
Neurol 64:1977-1978, Chin,P.S.,et al, 2005

Malignant Hyperthermia, Update on Susceptibility Testing
JAMA 293:2918-2924,2958, Litman,R.S.&Rosenberg,H., 2005

Prognositc Implications of Right-Sided Insular Damage, Cardiac Autonomic Derangement, and Arrhythmias After Acute Ischemic Stroke
Stroke 36:1710-1715, Colivicchi,F.,et al, 2005

Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients with Nonrheumatic ATrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 36:914-915, Saxena,R. &Koudstaal,P.J., 2005

Ximelagatran vs Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation
JAMA 293:690-698,736, SPORTIF Executive Steering Committee for the SPORTIF V Investigators, 2005

Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005

Ximelagatran--Promises and Concerns
JAMA 293:736-739, Gurewich,V., 2005

Cardiac Arrhythmias in Focal Epilepsy: A Prospective Long-Term Study
Lancet 364:2212-2219,2157, Rugg,F.J.,et al, 2004

Electrocardiographic Q-waves as a Predictor of Mortality in Patients with Cerebral Infarction
Neurol 62:1818-1821, Tanaka,M.,et al, 2004

Direct Thrombin Inhibition
Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004

Anticoagulants for Preventing Stroke in Patients with Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 35:1782-1783, Saxena,R. &Koudstaal,P.J., 2004

Combined Anticoagulant-Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients
Stroke 35:2362-2367, Shireman,T.I.,et al, 2004

Thrombolytic Therapy in Stroke-Related Trauma
Conn Med 68:551-553, Finelli,P.F. &Beland,D., 2004

Risk Factors for Intracardiac Thrombus in Patients with Recent Ischaemic Cerebrovascular Events
JNNP 75:1421-1425, Sen,S.,et al, 2004

Severe Cardiac Arrhythmias in Young Patients with Myotonic Dystrophy Type 1
Neurol 63:1939-1941, Bassez,G.,et al, 2004



Showing articles 500 to 550 of 982 << Previous Next >>